- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
回落整理中且下跌趋势有所减缓。
- 长期趋势：
已有238家主力机构披露2025-12-31报告期持股数据，持仓量总计3299.23万股，占流通A股7.93%
- 波段诊断：
-
技术面诊股
诊断结果：5.1技术面打败了27%的股票
技术面评分前10的股票
近期的平均成本为39.88元。多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
平均成本
近期的平均成本为39.88元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"39.88","date":1775981873,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑输行业平均水平。
[{"date":"2026.04.13","stock":"-1.02","trade":"-1.22","ind":"0.69"},{"date":"2026.04.10","stock":"1.11","trade":"0.70","ind":"2.24"},{"date":"2026.04.09","stock":"-3.40","trade":"-1.86","ind":"-0.33"},{"date":"2026.04.08","stock":"4.99","trade":"2.51","ind":"4.79"},{"date":"2026.04.07","stock":"0.36","trade":"0.66","ind":"0.36"},{"date":"2026.04.03","stock":"-3.55","trade":"-3.06","ind":"-0.99"},{"date":"2026.04.02","stock":"-1.39","trade":"-0.64","ind":"-1.60"},{"date":"2026.04.01","stock":"3.19","trade":"5.25","ind":"1.70"},{"date":"2026.03.31","stock":"-1.09","trade":"0.22","ind":"-1.81"},{"date":"2026.03.30","stock":"0.65","trade":"1.19","ind":"-0.25"},{"date":"2026.03.27","stock":"2.59","trade":"4.12","ind":"1.13"},{"date":"2026.03.26","stock":"-2.40","trade":"-0.95","ind":"-1.41"},{"date":"2026.03.25","stock":"1.60","trade":"1.63","ind":"1.95"},{"date":"2026.03.24","stock":"2.45","trade":"4.75","ind":"1.43"},{"date":"2026.03.23","stock":"-8.87","trade":"-5.76","ind":"-3.76"},{"date":"2026.03.20","stock":"-2.99","trade":"-2.55","ind":"-0.25"},{"date":"2026.03.19","stock":"-2.73","trade":"-3.01","ind":"-2.02"},{"date":"2026.03.18","stock":"1.04","trade":"0.92","ind":"1.05"},{"date":"2026.03.17","stock":"-0.92","trade":"-2.13","ind":"-1.87"},{"date":"2026.03.16","stock":"0.93","trade":"0.31","ind":"0.19"},{"date":"2026.03.13","stock":"-0.96","trade":"-0.19","ind":"-0.65"}]
华大基因,深证成指,医疗服务指数
压力支撑
该股压力位为39.84元，支撑位为39.62元。
[{"text":"\u538b\u529b\u4f4d","value":"39.84","date":1776009600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"39.62","date":1776009600,"color":"0x0b52a1"}]
多空趋势
多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.3资金面打败了42%的股票
主力控盘前10的股票
行业资金
医疗服务行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：04月13日 20:31
| 机构今日流向(万元) | -1676.71 | 机构5日流向(万元) | -1963.45 |
| 机构10日流向(万元) | -3003.10 | 机构20日流向(万元) | -7179.15 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少19556.34万股，其中基金净减仓34家，主力净减仓18家，请投资者中长期谨慎为宜。
截止2025-12-31，共238家主力机构（基金238家），持仓量总计3299.23万股，占流通A股7.93%
其中，基金持仓与2025-06-30相比：
增仓：68家 ，增持 368.42万股
减仓：102家 ，减持 381.65万股
新出现在主力名单中：58家 ，持有137.61万股
从主力名单中消失：76家 ，原持有19680.72万股
其中，基金持仓与2025-06-30相比：
增仓：68家 ，增持 368.42万股
减仓：102家 ，减持 381.65万股
新出现在主力名单中：58家 ，持有137.61万股
从主力名单中消失：76家 ，原持有19680.72万股
消息面诊股
诊断结果：5.5消息面打败了37%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 华大基因：4月10日获融资买入1404.49万元
2026-04-13 - 华大基因2026年供应链合作伙伴大会在青岛圆满举办
2026-04-11 - 基因检测龙头，两位副总同日请辞
2026-04-11 - 总投资超120亿，集聚人才3700+！青岛自贸片区
2026-04-10 - 行业周报|医疗服务指数涨1.97%, 跑输上证指数
2026-04-10 - 华大基因：4月9日获融资买入1900.72万元
2026-04-10 - 华大基因：4月8日获融资买入2117.33万元
2026-04-09 - 迄今最大规模NIPT一线筛查研究发布，河北模式助力
2026-04-08 - 2026-2030年中国基因检测行业投资价值与战略
2026-04-08 - 华大基因：4月7日获融资买入648.56万元
2026-04-08
消息列表
| 一般消息 | 高管变动 | 因个人原因 | 2026-04-10 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-03-20 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-03-03 |
| 一般消息 | 重大事项 | 关联交易 | 2026-02-12 |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-01-28 |
| 利好 | 业绩预告 | 预计减亏 | 2026-01-28 |
| 一般消息 | 募资投向 | 公司出售资产 | 2026-01-28 |
| 一般消息 | 重大事项 | 关联交易 | 2026-01-28 |
| 一般消息 | 高管变动 | 工作安排 | 2026-01-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-01-22 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-01-05 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-12-22 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-12-03 |
| 一般消息 | 高管变动 | 因工作安排原因 | 2025-11-12 |
| 一般消息 | 重大事项 | 关联交易 | 2025-10-24 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-09-30 |
| 一般消息 | 资产重组 | 公司股权转让 | 2025-09-22 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-09-15 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-23 |
| 一般消息 | 重大事项 | 关联交易 | 2025-08-23 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-08-20 |
| 一般消息 | 资产重组 | 公司股权转让 | 2025-07-29 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-06-20 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-06-17 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-26 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-26 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：3.2行业面打败了36%的股票
医疗服务行业最新资金流向
近10日来该行业走势不明显，接近大盘。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2026.04.13","price":"0.69","value":"-1.22"},{"date":"2026.04.10","price":"2.24","value":"0.70"},{"date":"2026.04.09","price":"-0.33","value":"-1.86"},{"date":"2026.04.08","price":"4.79","value":"2.51"},{"date":"2026.04.07","price":"0.36","value":"0.66"},{"date":"2026.04.03","price":"-0.99","value":"-3.06"},{"date":"2026.04.02","price":"-1.60","value":"-0.64"},{"date":"2026.04.01","price":"1.70","value":"5.25"},{"date":"2026.03.31","price":"-1.81","value":"0.22"},{"date":"2026.03.30","price":"-0.25","value":"1.19"},{"date":"2026.03.27","price":"1.13","value":"4.12"},{"date":"2026.03.26","price":"-1.41","value":"-0.95"},{"date":"2026.03.25","price":"1.95","value":"1.63"},{"date":"2026.03.24","price":"1.43","value":"4.75"},{"date":"2026.03.23","price":"-3.76","value":"-5.76"},{"date":"2026.03.20","price":"-0.25","value":"-2.55"},{"date":"2026.03.19","price":"-2.02","value":"-3.01"},{"date":"2026.03.18","price":"1.05","value":"0.92"},{"date":"2026.03.17","price":"-1.87","value":"-2.13"},{"date":"2026.03.16","price":"0.19","value":"0.31"},{"date":"2026.03.13","price":"-0.65","value":"-0.19"}]
深证成指,医疗服务行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 百奥赛图 | 29.02% | -11.31% | 7.0分 |
| 2 | 凯莱英 | 21.80% | -0.90% | 6.1分 |
| 3 | 药康生物 | 20.85% | 13.70% | 6.7分 |
| 4 | 益诺思 | 19.38% | 2.15% | 5.7分 |
| 5 | 药明康德 | 16.33% | 5.72% | 7.2分 |
| 6 | 皓元医药 | 14.26% | 7.92% | 6.3分 |
| 8 | 昭衍新药 | 12.13% | -0.71% | 6.1分 |
| 10 | 奥浦迈 | 9.33% | 16.26% | 6.7分 |
| 12 | 普瑞眼科 | 8.40% | 4.90% | 5.9分 |
| 14 | 阳光诺和 | 6.35% | 0.11% | 5.7分 |
| 16 | 百诚医药 | 3.65% | 6.36% | 4.9分 |
| 18 | 诺思格 | 2.14% | 0.50% | 6.2分 |
| 20 | 成都先导 | 1.98% | 0.54% | 5.8分 |
| 22 | 泰格医药 | 1.72% | 1.37% | 6.1分 |
| 24 | 大湖股份 | 1.06% | -1.62% | 5.4分 |
| 26 | 九洲药业 | 0.95% | -0.41% | 5.1分 |
| 28 | 南模生物 | 0.48% | 3.64% | 6.3分 |
| 30 | 百花医药 | -0.11% | -10.20% | 4.9分 |
| 32 | 博济医药 | -0.39% | 1.41% | 4.7分 |
| 34 | *ST生物 | -2.04% | 3.17% | 5.5分 |
| 36 | 和元生物 | -4.75% | 3.14% | 5.6分 |
| 38 | 爱尔眼科 | -5.31% | 1.26% | 4.8分 |
| 40 | 兰卫医学 | -6.33% | -0.20% | 5.2分 |
| 42 | 普蕊斯 | -7.03% | -1.99% | 5.5分 |
| 44 | 迪安诊断 | -8.51% | 1.54% | 5.1分 |
| 46 | 澳洋健康 | -9.60% | -0.52% | 5.1分 |
| 48 | 国际医学 | -9.90% | -2.67% | 4.5分 |
| 50 | 盈康生命 | -10.61% | -1.81% | 5.1分 |
| 52 | 皓宸医疗 | -11.15% | 2.41% | 4.2分 |
| 54 | 创新医疗 | -20.21% | 4.33% | 6.1分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 44/103 ， 19/103。
[{"date":"2025-09-30","value":"-0.23","vol":"3.27"},{"date":"2025-06-30","value":"0.06","vol":"2.25"},{"date":"2025-03-31","value":"-0.58","vol":"0.89"},{"date":"2024-12-31","value":"-9.51","vol":"-0.23"},{"date":"2024-09-30","value":"-1.26","vol":"3.08"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-0.23 | 0.06 | -0.58 | -9.51 | -1.26 |
| 行业(%) | 3.27 | 2.25 | 0.89 | -0.23 | 3.08 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"42.97","vol":"36.42"},{"date":"2025-06-30","value":"44.65","vol":"36.57"},{"date":"2025-03-31","value":"43.55","vol":"34.64"},{"date":"2024-12-31","value":"41.47","vol":"35.34"},{"date":"2024-09-30","value":"45.22","vol":"36.63"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
42.97 | 44.65 | 43.55 | 41.47 | 45.22 |
| 行业(%) | 36.42 | 36.57 | 34.64 | 35.34 | 36.63 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 38/103 ， 18/103。
[{"date":"2025-09-30","value":"-5.39","vol":"3.19"},{"date":"2025-06-30","value":"-12.82","vol":"3.02"},{"date":"2025-03-31","value":"-18.18","vol":"-0.59"},{"date":"2024-12-31","value":"-11.10","vol":"-0.26"},{"date":"2024-09-30","value":"-10.10","vol":"0.61"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-5.39 | -12.82 | -18.18 | -11.10 | -10.10 |
| 行业(%) | 3.19 | 3.02 | -0.59 | -0.26 | 0.61 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"82.78","vol":"21.04"},{"date":"2025-06-30","value":"-68.25","vol":"-63.64"},{"date":"2025-03-31","value":"-524.87","vol":"-24.37"},{"date":"2024-12-31","value":"-1071.68","vol":"-106.02"},{"date":"2024-09-30","value":"-276.49","vol":"-173.87"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
82.78 | -68.25 | -524.87 | -1071.68 | -276.49 |
| 行业(%) | 21.04 | -63.64 | -24.37 | -106.02 | -173.87 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 38/103 ， 30/103。
[{"date":"2025-09-30","value":"0.22","vol":"0.31"},{"date":"2025-06-30","value":"0.13","vol":"0.21"},{"date":"2025-03-31","value":"0.05","vol":"0.10"},{"date":"2024-12-31","value":"0.30","vol":"0.42"},{"date":"2024-09-30","value":"0.21","vol":"0.31"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.22 | 0.13 | 0.05 | 0.30 | 0.21 |
| 行业(次) | 0.31 | 0.21 | 0.10 | 0.42 | 0.31 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.72","vol":"11.00"},{"date":"2025-06-30","value":"1.55","vol":"7.17"},{"date":"2025-03-31","value":"0.65","vol":"3.69"},{"date":"2024-12-31","value":"3.76","vol":"15.82"},{"date":"2024-09-30","value":"2.35","vol":"13.74"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.72 | 1.55 | 0.65 | 3.76 | 2.35 |
| 行业(次) | 11.00 | 7.17 | 3.69 | 15.82 | 13.74 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"-2.19","vol":"16.58"},{"date":"2025-06-30","value":"-1.75","vol":"15.86"},{"date":"2025-03-31","value":"-59.10","vol":"-1.13"},{"date":"2024-12-31","value":"22.91","vol":"22.25"},{"date":"2024-09-30","value":"-6.53","vol":"13.47"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -2.19 | -1.75 | -59.10 | 22.91 | -6.53 |
| 行业 | 16.58 | 15.86 | -1.13 | 22.25 | 13.47 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.97","vol":"0.91"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.97","vol":"1.27"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.97 | - | 0.97 | - |
| 行业 | 0.01 | 0.91 | 0.00 | 1.27 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 25/103 ， 36/103。
[{"date":"2025-09-30","value":"2.81","vol":"3.73"},{"date":"2025-06-30","value":"2.81","vol":"3.63"},{"date":"2025-03-31","value":"2.85","vol":"3.81"},{"date":"2024-12-31","value":"2.42","vol":"3.63"},{"date":"2024-09-30","value":"2.63","vol":"4.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.81 | 2.81 | 2.85 | 2.42 | 2.63 |
| 行业 | 3.73 | 3.63 | 3.81 | 3.63 | 4.00 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.49","vol":"2.99"},{"date":"2025-06-30","value":"2.49","vol":"2.91"},{"date":"2025-03-31","value":"2.52","vol":"3.08"},{"date":"2024-12-31","value":"2.13","vol":"2.94"},{"date":"2024-09-30","value":"2.30","vol":"3.28"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.49 | 2.49 | 2.52 | 2.13 | 2.30 |
| 行业 | 2.99 | 2.91 | 3.08 | 2.94 | 3.28 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 32/103 ， 34/103。
[{"date":"2025-09-30","value":"23.82","vol":"32.51"},{"date":"2025-06-30","value":"24.81","vol":"33.52"},{"date":"2025-03-31","value":"26.68","vol":"32.55"},{"date":"2024-12-31","value":"26.08","vol":"33.22"},{"date":"2024-09-30","value":"24.94","vol":"30.77"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
23.82 | 24.81 | 26.68 | 26.08 | 24.94 |
| 行业(%) | 32.51 | 33.52 | 32.55 | 33.22 | 30.77 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.32","vol":"0.93"},{"date":"2025-06-30","value":"0.33","vol":"0.96"},{"date":"2025-03-31","value":"0.37","vol":"0.98"},{"date":"2024-12-31","value":"0.36","vol":"1.03"},{"date":"2024-09-30","value":"0.34","vol":"0.84"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.32 | 0.33 | 0.37 | 0.36 | 0.34 |
| 行业(%) | 0.93 | 0.96 | 0.98 | 1.03 | 0.84 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"14.62","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"8.03","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.93","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-9.03","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]